Published in J Hosp Infect on September 01, 2000
Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ (2004) 3.86
Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol (2003) 3.27
Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med (2006) 2.75
Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care (2006) 1.86
A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol (2004) 1.63
Patient referral patterns and the spread of hospital-acquired infections through national health care networks. PLoS Comput Biol (2010) 1.44
Hospital networks and the dispersal of hospital-acquired pathogens by patient transfer. PLoS One (2012) 1.20
Rapid identification of hospitalized patients at high risk for MRSA carriage. J Am Med Inform Assoc (2008) 1.02
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2011) 0.99
Patient sharing and population genetic structure of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2012) 0.97
Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: external invaders or persisting circulators? J Clin Microbiol (2009) 0.95
Hand hygiene--the case for evidence-based education. J R Soc Med (2001) 0.94
Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence (2013) 0.90
The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper. Can J Infect Dis (2004) 0.85
Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. J R Soc Interface (2012) 0.82
Ten-year decrease of acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at a single institution: the result of a multifaceted program combining cross-transmission prevention and antimicrobial stewardship. Antimicrob Resist Infect Control (2012) 0.81
Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series. PLoS One (2013) 0.76
Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team? Crit Care (2004) 0.75
Is pre-emptive strict isolation of patients at high risk of colonization with MRSA still required in low-prevalence countries? J Hosp Infect (2011) 0.75
Optimal use of MRSASelect and PCR to maximize sensitivity and specificity of MRSA detection. Curr Microbiol (2012) 0.75
Outbreak Column 13: Nosocomial Staphylococcus aureus outbreaks (part 2 - guidelines). J Infect Prev (2014) 0.75
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22
Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis (1991) 3.79
Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med (2001) 3.40
Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens. J Clin Microbiol (1997) 3.10
Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis (1988) 3.09
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis (1987) 2.71
Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol (1999) 2.68
Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg (1994) 2.68
Comparison of recovery of organisms from blood cultures diluted 10% (volume/volume) and 20% (volume/volume). J Clin Microbiol (1982) 2.42
Antibiotic prophylaxis before invasive dental procedures in patients with arthroplasties of the hip and knee. J Bone Joint Surg Br (2008) 2.35
Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA (1991) 2.32
'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect (2007) 2.31
Two different 16S rRNA genes in a mycobacterial strain. J Clin Microbiol (1996) 2.17
Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med (1998) 2.13
Evaluation of the new improved BHI-lysis blood culture medium for the BCB Roche system. Eur J Clin Microbiol Infect Dis (1991) 2.04
Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am Rev Respir Dis (1991) 2.02
Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00
Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect (2009) 1.94
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1999) 1.92
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med (1998) 1.89
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis (1991) 1.89
Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis (1989) 1.87
Scanning interferometric apertureless microscopy: optical imaging at 10 angstrom resolution. Science (1995) 1.80
Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerg Infect Dis (1999) 1.79
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis (2012) 1.79
In-vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother (1986) 1.71
Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infect Control Hosp Epidemiol (1996) 1.71
Clinical pharmacokinetics of the third generation cephalosporins. Clin Pharmacokinet (1985) 1.70
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.68
Sensitivity of clinical and behavioural tests of spatial neglect after right hemisphere stroke. J Neurol Neurosurg Psychiatry (2002) 1.67
Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2000) 1.67
Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect (2001) 1.67
A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med (1990) 1.63
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob Agents Chemother (1987) 1.62
Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet (2000) 1.61
Evaluation of the Wellcolex Colour Salmonella Test for detection of Salmonella spp. in enrichment broths. J Clin Microbiol (1992) 1.58
Predicting bacteremia in older patients. J Am Geriatr Soc (1995) 1.57
Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders? J Hosp Infect (2012) 1.49
Educating healthcare workers to optimal hand hygiene practices: addressing the need. Infection (2010) 1.49
Nurses and physicians' perceptions of the importance and impact of healthcare-associated infections and hand hygiene: a multi-center exploratory study in Hong Kong. Infection (2009) 1.49
Infection control in the ICU. Chest (2001) 1.48
Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis. Eur J Clin Microbiol Infect Dis (2005) 1.47
Behavioural considerations for hand hygiene practices: the basic building blocks. J Hosp Infect (2006) 1.43
Spondylodiscitis due to Propionibacterium acnes: report of twenty-nine cases and a review of the literature. Clin Microbiol Infect (2009) 1.41
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrob Agents Chemother (1982) 1.41
Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med (1996) 1.40
Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection (2006) 1.40
Veterinary prescription diets. Vet Rec (1991) 1.39
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother (1994) 1.37
Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35
Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis (1993) 1.34
Assessment of use of the COBAS AMPLICOR system with BACTEC 12B cultures for rapid detection of frequently identified mycobacteria. J Clin Microbiol (1999) 1.32
Environmental controls in operating theatres. J Hosp Infect (2002) 1.32
Combination therapy: a way to limit emergence of resistance? Am J Med (1986) 1.30
Prevention and control of health care-associated infections through improved hand hygiene. Indian J Med Microbiol (2010) 1.28
Comparison of immunological methods for diagnosis of pneumococcal pneumonia in biological fluids. Eur J Clin Microbiol (1987) 1.25
Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother (2000) 1.23
Influenza immunization: improving compliance of healthcare workers. Infect Control Hosp Epidemiol (1998) 1.22
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Secular trends of nocardia infection over 15 years in a tertiary care hospital. J Clin Pathol (2004) 1.22
Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect (2006) 1.21
Right spatial neglect after left hemisphere stroke: qualitative and quantitative study. Neurology (2004) 1.18
Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol (1998) 1.18
Comparison of BacT/Alert with Signal blood culture system. J Clin Microbiol (1995) 1.17
Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol (1998) 1.16
Molecular basis for cross-reactivity between a strain of Mycobacterium terrae and DNA probes for Mycobacterium tuberculosis complex. Eur J Clin Microbiol Infect Dis (1995) 1.16
Visualization of specific antibody and C1q binding to hapten-sensitized lipid vesicles. Proc Natl Acad Sci U S A (1978) 1.15
International collaborative evaluation of the ATB 32 staph gallery for identification of the Staphylococcus species. Zentralbl Bakteriol (1990) 1.14
Specific antibody-dependent binding of complement component C1q to hapten-sensitized lipid vesicles. Proc Natl Acad Sci U S A (1978) 1.13
Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med (1989) 1.12
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1988) 1.11
Evaluation of the Bactec 960 automated nonradiometric system for isolation of mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis (2000) 1.10
Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol (1992) 1.09
Spontaneous and chemoattractant-induced oscillations of cytosolic free calcium in single adherent human neutrophils. J Biol Chem (1988) 1.08
Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-the-art update. J Hosp Infect (2013) 1.08
Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect (2010) 1.06
Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med (1991) 1.05
Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control. J Hosp Infect (2008) 1.05
The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents. Clin Infect Dis (1998) 1.04
Nonselective inhibition of neutrophil functions by sphinganine. J Biol Chem (1987) 1.03
Chronic destructive lung disease associated with a novel mycobacterium. Am J Respir Crit Care Med (1994) 1.03
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. Neuroreport (1998) 1.03
[Disseminated infection with Mycobacterium celatum]. Schweiz Med Wochenschr (1996) 1.03
Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital. Swiss Med Wkly (2009) 1.03
Rapid diagnosis of gram negative pneumonia by assay of endotoxin in bronchoalveolar lavage fluid. Thorax (1992) 1.02